Truncal fat determined by dual-energy X-ray absorptiometry is an independent predictor of coronary artery disease extension

European Journal of Preventive Cardiology

Volumn 15, Issue 4, 2008, Pages 428-433

  Bestetti, Alberto ^a   Castini, Diego ^b   Bigi, Riccardo ^d   Maioli, Claudio ^a   Lombardi, Federico ^b   Gregori, Dario ^e   Cornalba, Gianpaolo ^c  

^a Nuclear Medicine Department   (Italy)

^b Division of Cardiology   (Italy)

^c Medical School   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e UNIVERSITY OF TURIN   (Italy)

Author keywords

coronary artery disease; dual energy X ray absorptiometry; truncal fat

Indexed keywords

ANGIOCARDIOGRAPHY; ANTHROPOMETRY; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; CORONARY ARTERY DISEASE; FEMALE; HUMAN; MALE; MIDDLE AGED; OBESITY; PHOTON ABSORPTIOMETRY; RADIOGRAPHY; WAIST HIP RATIO; ABDOMINAL OBESITY; ADIPOSE TISSUE; ADULT; AGE DISTRIBUTION; BODY COMPOSITION; DISEASE ASSOCIATION; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; MAJOR CLINICAL STUDY; PHYSICAL EXAMINATION; PREDICTION; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING HABIT; TRUNK; WAIST CIRCUMFERENCE;

ABSORPTIOMETRY, PHOTON; ANTHROPOMETRY; BODY FAT DISTRIBUTION; BODY MASS INDEX; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; WAIST-HIP RATIO;

EID: 55249125970     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/HJR.0b013e3282fb2e05     Document Type: Article

References (37)

1. World Health Organization. Obesity: preventing and managing the global epidemic: report of a WHO Consultation on Obesity. Geneva: WHO; 1999. (Technical report series no. 894). Available at http://whqlibdoc.who.int/trs/WHO_TRS_894.pdf (accessed 18 August 2007).
2. National Institutes of Health, National Heart, Lung and Blood Institute. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Bethesda (MD): National Institutes of Health; 1998. NIH Publication no. 98–4083.
3. Bray GA, Ryan GH. Clinical evaluation of the overweight patient. Endocrine 2000; 13: 167–186.
4. Lean ME, Han TS, Seidell JC. Impairment of health and quality of life using new US federal guidelines for the identification of obesity. Arch Intern Med 1999; 159: 837–843.
5. Pi-Sunier FX. Weight loss and mortality in type 2 diabetes. Diabetes Care 2000; 23: 1451–1452.
6. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67: 968–977.
7. Rimm EB, Stampfer MJ, Giovannucci E, Ascherio A, Spiegelman D, Colditz GA, Willett WC. Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. Am J Epidemiol 1995; 141: 1117–1127.
8. Eckel RH, Krauss RM. American Heart Association call to action: obesity as a major risk factor for coronary heart disease: AHA Nutrition Committee. Circulation 1998; 97: 2099–2100.
9. Manson JE, Colditz GA, Stampfer MJ, Willet WC, Rosner B, Monson RR, et al A prospective study of obesity and risk of coronary heart disease in women. New Engl J Med 1990; 322: 882–889.
10. Wolk R, Berger P, Lennon RJ, Brilakis ES, Somers VK. Body mass index. A risk factor for unstable angina and myocardial infarction in patients with angiographically confirmed coronary artery disease. Circulation 2003; 108: 2206–2211.
11. Hodgson JM, Wahlquist ML, Balazs ND, Boxall JA. Coronary atherosclerosis in relation to body fatness and its distribution. Int J Obes Relat Metab Disord 1994; 18: 41–46.
12. Hartz A, Grubb B, Wild R, Van Nort JJ, Kuhn E, Freedman D, Rimm A. The association of waist hip ratio and angiographically determined coronary artery disease. Int J Obesity 1990; 14: 657–665.
13. Hauner H, Stangl K, Schmatz C, Burger K, Blomer H, Pfeiffer EF. Body fat distribution in men with angiographically confirmed coronary artery disease. Atherosclerosis 1990; 85: 203–210.
14. Zamboni M, Armellini F, Sheiban I, De Marchi L, Todesco T, Bergamo-Andreis IA, et al Relation of body fat distribution in men and degree of coronary narrowings in coronary artery disease. Am J Cardiol 1992; 70: 1135–1138.
15. Holmes DR, Elveback LR, Frye RL, Kottke BA, Ellefson RD. Association of risk factor variables and coronary artery disease documented with angiography. Circulation 1981; 63: 293–299.
16. Hauner H, Bognar E, Blum A. Body fat distribution and its association with metabolic and hormonal risk factors in women with angiographically assessed coronary artery disease. Evidence for the presence of a metabolic syndrome. Atherosclerosis 1994; 105: 209–216.
17. Tanaka K, Kodama H, Sasazuki S, Yoshimasu K, Liu Y, Tokunaga S, et al Obesity, body fat distribution and coronary atherosclerosis among Japanese men and women. Int J Obesity 2001; 25: 191–197.
18. Abate N, Garg A, Peshock RM, Stray-Gundersen J, Grundy SM. Relationship of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest 1995; 96: 88–98.
19. Paradisi G, Smith L, Burtner C, Learning R, Garvey WT, Hook G, et al Dual energy X-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome. Diabetes Care 1999; 22: 1310–1317.
20. Garg A. Regional adiposity and insulin resistance. J Clin Endocrinol Metab 2004; 89: 4206–4210.
21. Vega GL, Adams-Huet B, Peshock R, Willet DW, Shah B, Grundy SM. Influence of body fat content and distribution on variation in metabolic risk. J Clin Endocrinol Metab 2006; 91: 4459–4466.
22. Haarbo J, Gotfredsen A, Hassager C, Christiansen C. Validation of body composition by dual-energy X-ray absorpiometry (DEXA). Clin Physiol 1991; 11: 331–341.
23. Svendsen OL, Haarbo J, Hassager C, Christiansen C. Accuracy of measurement of body composition by dual-energy X-ray absorpiometry in vivo. Am J Clin Nutr 1993; 57: 605–608.
24. Taaffe DR, Lewis R, Marcus R. Regional fat distribution by dual energy X-ray absorptiometry: comparison with anthropometry and application in a clinical trial of growth hormone and exercise. Clin Sci 1994; 87: 581–586.
25. Taylor RW, Keil D, Gold EJ, Williams SM, Goulding A. Body mass index, waist girth, and waist to hip ratio as indexes of total and regional adiposity in women: evaluation using receiver operating characteristic curves. Am J Clin Nutr 1998; 67: 44–49.
26. World Health Organization. Physical status: the use and interpretation of anthropometry: report of WHO expert Committee. WHO technical report series 854. Geneva: World Health Organization; 1995.
27. James WPT. The epidemiology of obesity. In: Chadwick DJ, Cardew G, editors. The origins and consequences of obesity. Chichester (UK): Wiley; 1996: 1–16.
28. Gensini GG. A more meaningful scoring system for determining the severity of coronary artery disease. Am J Cardiol 1983; 51: 606.
29. Sullivan DR, Marwick TH, Freedman SB. A new method of scoring coronary angiograms to reflect the extent of coronary atherosclerosis and improve correlation with major risk factors. Am Heart J 1990; 119: 1262–1267.
30. Kanaya AM, Vittinghoff E, Shlipak MG, Resnick HE, Visser M, Grady D, Barrett-Connor E. Association of total and central obesity with mortality in postmenopausal women with CAD. Am J Epidemiol 2003; 158: 1161–1170.
31. Ninomiya JK, L'ltalien G, Criqui MH, Whyte JL, Gamst A, Chen RS. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation 2004; 109: 42–46.
32. Sonmez K, Akcakoyun M, Akcay A, Demir D, Duran NE, Gençbay M, et al Which method should be used to determinate the obesity, in patients with coronary artery disease? (body mass index, waist circumference or waist-hip ratio). Int J Obes Relat Metab Disord 2003; 27: 341–346.
33. Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, et al Abdominal visceral and subcutaneous adipose tissue compartments. Association with metabolic risk factors in the Framingham Heart study. Circulation 2007; 116: 39–48.
34. Samad F, Pandery M, Loskutoff DJ. Tissue factor gene expression in the adipose tissue of obese mice. Proc Natl Acad Sci U S A 1998; 95: 7591–7596.
35. Davi D, Guagnano MT, Ciabattoni G. Platelet activation in obese women: role of inflammation and oxidant stress. J Am Med Assoc 2002; 288: 2008–2014.
36. Bastard JP, Pieroni L. Plasma plasminogen activator inhibitor 1, insulin resistance and android obesity. Biomed Pharmacother 1999; 53: 455–461.
37. Tseng CH. Body composition as a risk factor for coronary artery disease in Chinese type 2 diabetic patients in Taiwan. Circ J 2003; 67: 479–484.